» Articles » PMID: 16222702

Increased HEXIM1 Expression During Erythroleukemia and Neuroblastoma Cell Differentiation

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2005 Oct 14
PMID 16222702
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The HEXIM1 protein, in association with 7SK snRNA, binds and inhibits the kinase activity of P-TEFb (CDK9/cyclin T). P-TEFb activity is crucial for efficient transcription elongation of viral and cellular genes. HEXIM1 was originally isolated as a protein up-regulated by hexamethylene bisacetamide (HMBA), a prototypical inducer of differentiation. To determine the causative role of HEXIM1 during cell differentiation we analyzed the biochemical and functional consequences of HEXIM1 protein levels in several in vitro differentiation systems. We found that HEXIM1 mRNA and protein levels are up-regulated during differentiation of murine erythroleukemia cells upon treatment with HMBA or DMSO. Stimulation of HEXIM1 is not restricted to hematopoietic cells, as induction of phenotypic differentiation of neuroblastoma cells by retinoic acid results in up-regulation of HEXIM1. Moreover, ectopic expression of HEXIM1 causes growth inhibition and promotes neuronal differentiation. These findings highlight a crucial role of HEXIM1 protein during cell differentiation.

Citing Articles

HMBA ameliorates obesity by MYH9- and ACTG1-dependent regulation of hypothalamic neuropeptides.

Park S, Oh S, Kim N, Kim E EMBO Mol Med. 2023; 15(12):e18024.

PMID: 37984341 PMC: 10701615. DOI: 10.15252/emmm.202318024.


CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.

Anshabo A, Milne R, Wang S, Albrecht H Front Oncol. 2021; 11:678559.

PMID: 34041038 PMC: 8143439. DOI: 10.3389/fonc.2021.678559.


Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.

Hamada M, Yura Y Int J Mol Sci. 2020; 21(19).

PMID: 32992948 PMC: 7582277. DOI: 10.3390/ijms21197073.


Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.

Montano M, Yeh I, Chen Y, Hernandez C, Kiselar J, Fuente M Breast Cancer Res. 2019; 21(1):138.

PMID: 31805991 PMC: 6896798. DOI: 10.1186/s13058-019-1228-7.


CDK9 inhibitors in acute myeloid leukemia.

Boffo S, Damato A, Alfano L, Giordano A J Exp Clin Cancer Res. 2018; 37(1):36.

PMID: 29471852 PMC: 5824552. DOI: 10.1186/s13046-018-0704-8.